Login / Signup

Impact of chiglitazar on glycemic control in type 2 diabetic patients with metabolic syndrome and insulin resistance: A pooled data analysis from two phase III trials.

Zhiqiang NingGuoqiang AiBo ChenHe YaoHaixiang CaoDesi PanXianping Lu
Published in: Journal of diabetes (2023)
Chiglitazar shows promising efficacy for glycemic control in patients with T2DM associated with MetS or IR. Further prospective trials are required to validate these findings.
Keyphrases